Hansa Biopharma publishes Annual Report 2021

Corporate Breaking News

Home : Hansa Biopharma publishes Annual Report 2021

Apr 07 2022	Hansa Biopharma publishes Annual Report 2021
LUND, Sweden, April 7, 2022 /PRNewswire/ -- Hansa Biopharma AB "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the Annual Report 2021 Søren Tulstrup, President and CEO of Hansa Biopharma, comments: 2021...


Source:https://www.prnewswire.com:443/news-releases/hansa-biopharma-publishes-annual-report-2021-301519710.html

Related News
» Heat Treated Steel Plates Market -78% of Growth to Originate from APAC \|Driven by Growing Demand from the Construction Industry \| 17000+ Technavio Reports » New Professional Ski and Snowboard Wear Standard in China